Albert Labs International Corp. operates as a research and drug development company. It produces natural pharmaceutical-quality psilocybin medicine to treat cancer-related distress. The firm focuses on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways. The company is headquartered in Burnaby, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Albert Labs International Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Albert Labs International Corp market cap is $372,100.00.
What is the 52-week high for Albert Labs International Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Albert Labs International Corp 52 week high is $0.005 as of September 07, 2025.
What is the 52-week low for Albert Labs International Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Albert Labs International Corp 52 week low is $0.005 as of September 07, 2025.
What is Albert Labs International Corp stock price today?
Albert Labs International Corp stock price today is $0.005.
What was Albert Labs International Corp stock price yesterday?
Albert Labs International Corp stock price yesterday was $0.01.
What is the 50-day moving average of Albert Labs International Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Albert Labs International Corp 50-day moving average is $0.005.